Re: Chen S, Shi M, Shen L, et al. Microwave ablation versus sorafenib for intermediate-stage hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis. Int J hyperthermia 2020

Bibliographic Details
Main Authors: Zhaonan Li, Xinwei Han
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:International Journal of Hyperthermia
Online Access:http://dx.doi.org/10.1080/02656736.2020.1847331
id doaj-b83676470f3d448093cc6b7c6d36de0c
record_format Article
spelling doaj-b83676470f3d448093cc6b7c6d36de0c2021-08-09T15:50:03ZengTaylor & Francis GroupInternational Journal of Hyperthermia0265-67361464-51572020-01-013711312131210.1080/02656736.2020.18473311847331Re: Chen S, Shi M, Shen L, et al. Microwave ablation versus sorafenib for intermediate-stage hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis. Int J hyperthermia 2020Zhaonan Li0Xinwei Han1Department of Interventional Radiology, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Interventional Radiology, The First Affiliated Hospital of Zhengzhou Universityhttp://dx.doi.org/10.1080/02656736.2020.1847331
collection DOAJ
language English
format Article
sources DOAJ
author Zhaonan Li
Xinwei Han
spellingShingle Zhaonan Li
Xinwei Han
Re: Chen S, Shi M, Shen L, et al. Microwave ablation versus sorafenib for intermediate-stage hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis. Int J hyperthermia 2020
International Journal of Hyperthermia
author_facet Zhaonan Li
Xinwei Han
author_sort Zhaonan Li
title Re: Chen S, Shi M, Shen L, et al. Microwave ablation versus sorafenib for intermediate-stage hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis. Int J hyperthermia 2020
title_short Re: Chen S, Shi M, Shen L, et al. Microwave ablation versus sorafenib for intermediate-stage hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis. Int J hyperthermia 2020
title_full Re: Chen S, Shi M, Shen L, et al. Microwave ablation versus sorafenib for intermediate-stage hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis. Int J hyperthermia 2020
title_fullStr Re: Chen S, Shi M, Shen L, et al. Microwave ablation versus sorafenib for intermediate-stage hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis. Int J hyperthermia 2020
title_full_unstemmed Re: Chen S, Shi M, Shen L, et al. Microwave ablation versus sorafenib for intermediate-stage hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis. Int J hyperthermia 2020
title_sort re: chen s, shi m, shen l, et al. microwave ablation versus sorafenib for intermediate-stage hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis. int j hyperthermia 2020
publisher Taylor & Francis Group
series International Journal of Hyperthermia
issn 0265-6736
1464-5157
publishDate 2020-01-01
url http://dx.doi.org/10.1080/02656736.2020.1847331
work_keys_str_mv AT zhaonanli rechensshimshenletalmicrowaveablationversussorafenibforintermediatestagehepatocellularcarcinomawithtranscatheterarterialchemoembolizationrefractorinessapropensityscorematchinganalysisintjhyperthermia2020
AT xinweihan rechensshimshenletalmicrowaveablationversussorafenibforintermediatestagehepatocellularcarcinomawithtranscatheterarterialchemoembolizationrefractorinessapropensityscorematchinganalysisintjhyperthermia2020
_version_ 1721213806201274368